ScholarIQanswers from OpenAlex & ORCID
J. Scott Andrews
ResearcherPublications, citations & collaboration network
J. Scott Andrews is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does J. Scott Andrews have?
ScholarIQindexed works
J. Scott Andrews has 81 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does J. Scott Andrews have?
ScholarIQcitation count
J. Scott Andrews has 3,586 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of J. Scott Andrews?
ScholarIQh-index
J. Scott Andrews has an h-index of 18 in OpenAlex.
What is the i10-index of J. Scott Andrews?
ScholarIQi10-index
J. Scott Andrews has an i10-index of 20 in OpenAlex.
What is the ORCID of J. Scott Andrews?
ScholarIQorcid
The ORCID for J. Scott Andrews is on the source record.
What is the OpenAlex record for J. Scott Andrews?
ScholarIQopenalex
The OpenAlex for J. Scott Andrews is on the source record.
What are the most-cited papers on J. Scott Andrews?
ScholarIQmost cited works
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
Clifford R. Jack, J. Scott Andrews, Thomas G. Beach, Teresa Buracchio, Billy Dunn, Ana Graf, Oskar Hansson, Carole Ho, William J. Jagust, Eric McDade, José Luís Molinuevo, Ozioma C. Okonkwo, Luca Pani, Michael S. Rafii, Philip Scheltens, Eric Siemers, Heather M. Snyder, Reisa A. Sperling, Charlotte E. Teunissen, Marı́a C. Carrillo
Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials
J. Scott Andrews, Urvi Desai, Noam Y. Kirson, Miriam L. Zichlin, Daniel Ball, Brandy R. Matthews
Expectations and clinical meaningfulness of randomized controlled trials
Ronald C. Petersen, Paul Aisen, J. Scott Andrews, Alireza Atri, Brandy R. Matthews, Dorene M. Rentz, Eric Siemers, Christopher J. Weber, María C. Carrillo
Costs of Early Stage Alzheimer’s Disease in the United States: Cross-Sectional Analysis of a Prospective Cohort Study (GERAS-US)1
R.L. Robinson, Dorene M. Rentz, J. Scott Andrews, Anthony J. Zagar, Yongin Kim, Valerie Bruemmer, Ronald L. Schwartz, Wenyu Ye, Howard Fillit
Factors associated with long-term impact on informal caregivers during Alzheimer’s disease dementia progression: 36-month results from GERAS
Catherine Reed, Mark Belger, J. Scott Andrews, Antje Tockhorn‐Heidenreich, Roy Jones, Anders Wimo, Richard Dodel, Josep María Haro